Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 949 of 5804
-
Blood tests may guide breast cancer treatment before surgery
Knowledge-focused Not yet recruitingTo learn whether certain blood and imaging tests can show which people with early-stage TNBC may already have had a complete response to chemotherapy before they go to surgery.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC
-
New combo aims to shield bone marrow in tough breast cancer
Disease control Not yet recruitingTriple negative breast cancer (TNBC) has attracted much attention due to its young age of onset, high aggressiveness, lack of clear therapeutic targets and poor clinical prognosis.Eribulin is a novel non-taxane anti-microtubule inhibitor with unique microtubule and non-microtubul…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New drug trial aims to rescue failing lungs after transplant
Disease control Not yet recruitingThis study is testing a medication called emapalumab to see if it can help people who have had a lung transplant and are experiencing a sudden drop in lung function, called acute lung allograft dysfunction (ALAD). ALAD is a serious condition that can happen after a lung transpla…
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New sleep therapy aims to boost brain health in veterans
Symptom relief Not yet recruitingInsomnia is a transdiagnostic health problem affecting the physical, cognitive, emotional, and social functioning of Veterans. Importantly, chronic insomnia may be a modifiable risk factor for progression to serious health conditions, such as mild cognitive impairment (MCI) and d…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
New Hormone-Free drug for hot flashes tested in real life
Symptom relief Not yet recruitingMenopause is a natural stage in a woman's life happening between ages 45 and 55. It is often associated with disruptive symptoms like hot flashes and sleep disturbances that can affect up to 8 out of 10 women and make daily life harder. Elinzanetant is a new, hormone free medicin…
Sponsor: Bayer • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Veterans with opioid addiction may soon get pain relief from a web program
Symptom relief Not yet recruitingChronic pain is common in individuals with opioid use disorder (OUD) and the first-line treatment, Medication for OUD (MOUD), does not address the considerable functional impairments associated with chronic pain. Veterans with OUD and chronic pain could benefit from integrated, b…
Phase: PHASE3 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New approach aims to slash opioid use after wisdom tooth surgery
Disease control TerminatedReducing opioid prescription related use and misuse is a major focus for countering the national epidemic of opioid overdose and death. Annually, over 3.5 million predominantly young and healthy individuals undergo outpatient third molar ('wisdom tooth') tooth extractions under s…
Phase: PHASE2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a smartphone app help melanoma patients avoid severe side effects from immunotherapy?
Symptom relief Not yet recruitingThis clinical trial tests the feasibility of patient reported outcomes monitoring with early, rapid immunotherapy toxicity subspecialty care to improve side effect management for patients with melanoma receiving an immune checkpoint inhibitor. Immune checkpoint inhibitors have im…
Phase: NA • Sponsor: OHSU Knight Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
New PET tracer may reveal which bile duct cancers resist standard therapy
Diagnosis Not yet recruitingThis phase II trial studies whether \[18F\]FTT can be used with positron emission tomography (PET)/computed tomography (CT) imaging to predict treatment response in patients scheduled to receive gemcitabine, cisplatin, and durvalumab (GCD) for newly diagnosed cholangiocarcinoma. …
Phase: PHASE2 • Sponsor: University of Washington • Aim: Diagnosis
Last updated Jul 01, 2026 00:00 UTC
-
Can a chemo combo without anthracyclines still beat breast cancer?
Knowledge-focused Not yet recruitingThe goal of this observational, retrospective, non interventional study is to learn about the efficacy of an Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early Triple-Negative Breast Cancer (TNBC). The main question it aims to answer is : \- What is the efficacy of this…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Newborn SCID screening study aims to unlock secrets of immune disorders
Knowledge-focused Not yet recruitingSince September 2025, neonatal screening for severe combined immunodeficiency (SCID) has been generalized in France. These genetic disorders, which are asymptomatic at birth, cause severe immunodeficiency, exposing infants to serious infections (viral, bacterial, or fungal) as ea…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Virtual nature walks could lift mood for elderly patients stuck in hospital
Symptom relief Not yet recruitingProlonged hospitalization can reduce opportunities for independent activity, choice, and control and may contribute to passivity, low mood, anxiety, and distress in some older adults. Zenctuary VR+ is a seated, nature-based virtual reality program that combines calming environmen…
Phase: NA • Sponsor: Moholy-Nagy University of Art and Design • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
Can a common blood thinner outsmart a hidden heart risk?
Disease control Not yet recruitingThe Lp(a)-PLAT Study is designed to close a critical evidence gap in cardiovascular prevention for the roughly 20% of the population who carry genetically determined elevations in lipoprotein(a) - a recognised pro-thrombotic and pro-atherosclerotic risk factor. Its objective is t…
Phase: NA • Sponsor: François MACH • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Radioactive drug aims to supercharge cancer immunotherapy
Disease control Recruiting nowParticipants with metastatic cancer who are taking anti-PD-1 or anti-PD-L1 therapy will be enrolled to assess the safety of and find the optimal dose for radioactive imaging agents and to explore whether these agents will make current drug therapies work better. Up to 60 particip…
Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Virtual bees and wasps may alter allergy immune responses — a trial puts it to the test
Knowledge-focused Not yet recruitingThis study investigates whether immersive virtual reality (VR) exposure to allergen-related stimuli can modulate behavioural, neurophysiological, psychophysiological, and immune responses in adults with bee or wasp venom allergy. The study consists of two parts. In Part 1, adult…
Phase: NA • Sponsor: University of Geneva, Switzerland • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Can a smart sensor keep heart failure patients out of the hospital?
Disease control Not yet recruitingHeart failure (HF) is a major cause of hospital admissions in the US, with over 6 million hospital days annually. More than 40% of hospitalized patients with HF have diabetes mellitus (DM), which increases the risk of recurrent hospitalizations for HF with reduced and preserved …
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Exoskeleton walking plus spinal stimulation may help rebuild muscle and bone after paralysis
Disease control Not yet recruitingImmobilization following spinal cord injury (SCI) results in muscle and bone loss below the level of injury, which ultimately predisposes to fracture at several sites throughout the legs and can lead to several medical complications that can devastate quality of life. There is a …
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New drug hope for rare throat and thyroid cancers
Disease control Not yet recruitingThis is an open-label, investigator-initiated phase II clinical trial designed to evaluate the efficacy and safety of Sacituzumab Tirumotecan (sac-TMT) monotherapy in patients with recurrent or metastatic adenoid cystic carcinoma (ACC) of salivary gland origin and papillary thyro…
Phase: PHASE2 • Sponsor: National Cancer Centre, Singapore • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Keyhole surgery may beat standard care for chest infections
Disease control Not yet recruitingThe PROMPT study is testing whether an early keyhole procedure called Medical Thoracoscopy, which lets doctors look inside the chest and remove infected fluid, works better than current standard treatment (medicines to break up thick fluid) for people with pleural infection. Abou…
Phase: NA • Sponsor: Università Politecnica delle Marche • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
App aims to cut Post-Surgery complications in digestive cancer patients
Symptom relief TerminatedIn France, digestive cancers are responsible for more than 40,000 deaths per year, or approximately 30% of cancer-related deaths. Surgery is central to the patient's journey, particularly their treatment, and postoperative complications, whether cardiovascular, respiratory, infe…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC